Iguana Biotec
Iguana Biotechnology GmbH (Iguana), an innovative BioTech start-up based in Munich, Germany, is pursuing as lead candidate the development of a therapeutic vaccine against Helicobacter pylori, one of the most common infectious diseases worldwide. Currently, about 50% of the world's population is affected by this infection. Early diagnosis and treatment of the infection can significantly reduce the risk of serious gastric diseases such as gastric ulcers, MALT lymphoma and gastric cancer. Due to increasing resistance to conventional antibiotic therapy, the development of effective therapeutic alternatives is essential. Iguana's innovative approach to a therapeutic vaccine meets the urgent need for a therapeutic alternative and to increase the prevention of gastric cancer.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Iguana Biotec
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Iguana Biotec
2 distinct titles indexed · top 2 shown.
- 1director of research & development
- 1junior scientist
Sign up to unlock all 2 contacts at Iguana Biotec
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Iguana Biotec
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.